Uncategorized - Express Pharma

JB Pharma announces ESG commitments with launch of third sustainability report

Alembic Pharmaceuticals announces USFDA final approval for Nelarabine injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial)

FDA updates guidance to address spread of misinformation

Total prevalent cases of osteoporosis to cross 58.05 mn in 7MM by 2033: GlobalData

Asahi Kasei Medical completes new assembly plant for Planova virus removal filters

Taro shareholders approve merger with Sun Pharma

The trailblazers among us: honouring India’s clinical research professionals

Alembic Pharmaceuticals receives an EIR for its oncology formulation facility

Decoding the skirmish over revised Schedule M

Why does Pycnogenol® offer such a wide range of health benefits?